Cutaneous Nontuberculous Mycobacteria Infections Following Cosmetic Procedures: A Retrospective Study.

IF 2.9 3区 医学 Q2 INFECTIOUS DISEASES
Infection and Drug Resistance Pub Date : 2025-05-06 eCollection Date: 2025-01-01 DOI:10.2147/IDR.S517138
Rui Zeng, Jingshu Xiong, Wei Gao, Jiayi Peng, Ying Shi, Wenyue Zhang, Haiqin Jiang, Chaojiang Cheng, Gai Ge, Zhenzhen Wang, Youming Mei, Zhiming Chen, Hongsheng Wang
{"title":"Cutaneous Nontuberculous Mycobacteria Infections Following Cosmetic Procedures: A Retrospective Study.","authors":"Rui Zeng, Jingshu Xiong, Wei Gao, Jiayi Peng, Ying Shi, Wenyue Zhang, Haiqin Jiang, Chaojiang Cheng, Gai Ge, Zhenzhen Wang, Youming Mei, Zhiming Chen, Hongsheng Wang","doi":"10.2147/IDR.S517138","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Reports of skin infections associated with nontuberculous mycobacteria (NTM) following cosmetic procedures are increasing. The diagnosis and treatment of these infections remain a significant challenge for clinicians.</p><p><strong>Objective: </strong>We examined the clinical characteristics, microbiology, histopathology, and treatment strategies of NTM infections following cosmetic procedures, including botulinum toxin injection, lipolysis injection, hyaluronic acid injection, mesotherapy, autologous fat grafting, and other related procedures.</p><p><strong>Methods: </strong>This retrospective study of cosmetology-related cutaneous NTM infections diagnosed based on culture or molecular identification was conducted at a tertiary dermatology hospital in China. Demographic, clinical, microbiological, pathological biopsy, management, and outcome data were also collected.</p><p><strong>Results: </strong>The series enrolled 28 patients, four diagnosed by molecular identification and histology, and 24 by positive culture. All 24 NTM cultures were rapid-growing mycobacteria, mainly <i>Mycobacterium abscessus</i> complex (75%), with a mean time to positive culture of 11.8 days. The mean incubation period for the lesions was three weeks, while the mean time to diagnosis was 9.8 weeks. Treatment typically requires long-term, multi-drug therapy. Surgical intervention may shorten the disease course.</p><p><strong>Conclusion: </strong>Cosmetology-related cutaneous NTM infections are frequently underrecognized and challenging to diagnose, leading to delayed treatment. We aimed to enhance clinician awareness of NTM infections to facilitate early detection and prompt treatment. Empirical therapy with clarithromycin and moxifloxacin may be considered in the absence of susceptibility results, but treatment decisions should be carefully guided by susceptibility testing results. Surgical intervention may be beneficial, and tigecycline is a viable option when resistant to clarithromycin.</p>","PeriodicalId":13577,"journal":{"name":"Infection and Drug Resistance","volume":"18 ","pages":"2301-2309"},"PeriodicalIF":2.9000,"publicationDate":"2025-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12065458/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Infection and Drug Resistance","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/IDR.S517138","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Reports of skin infections associated with nontuberculous mycobacteria (NTM) following cosmetic procedures are increasing. The diagnosis and treatment of these infections remain a significant challenge for clinicians.

Objective: We examined the clinical characteristics, microbiology, histopathology, and treatment strategies of NTM infections following cosmetic procedures, including botulinum toxin injection, lipolysis injection, hyaluronic acid injection, mesotherapy, autologous fat grafting, and other related procedures.

Methods: This retrospective study of cosmetology-related cutaneous NTM infections diagnosed based on culture or molecular identification was conducted at a tertiary dermatology hospital in China. Demographic, clinical, microbiological, pathological biopsy, management, and outcome data were also collected.

Results: The series enrolled 28 patients, four diagnosed by molecular identification and histology, and 24 by positive culture. All 24 NTM cultures were rapid-growing mycobacteria, mainly Mycobacterium abscessus complex (75%), with a mean time to positive culture of 11.8 days. The mean incubation period for the lesions was three weeks, while the mean time to diagnosis was 9.8 weeks. Treatment typically requires long-term, multi-drug therapy. Surgical intervention may shorten the disease course.

Conclusion: Cosmetology-related cutaneous NTM infections are frequently underrecognized and challenging to diagnose, leading to delayed treatment. We aimed to enhance clinician awareness of NTM infections to facilitate early detection and prompt treatment. Empirical therapy with clarithromycin and moxifloxacin may be considered in the absence of susceptibility results, but treatment decisions should be carefully guided by susceptibility testing results. Surgical intervention may be beneficial, and tigecycline is a viable option when resistant to clarithromycin.

美容手术后皮肤非结核分枝杆菌感染:一项回顾性研究。
背景:美容手术后与非结核分枝杆菌(NTM)相关的皮肤感染报告正在增加。这些感染的诊断和治疗仍然是临床医生面临的重大挑战。目的:探讨美容手术后NTM感染的临床特征、微生物学、组织病理学和治疗策略,包括肉毒杆菌毒素注射、脂解注射、透明质酸注射、美施疗法、自体脂肪移植等相关手术。方法:回顾性研究在中国某三级皮肤科医院进行的基于培养或分子鉴定诊断的美容相关皮肤NTM感染。还收集了人口统计学、临床、微生物学、病理活检、管理和结果数据。结果:共纳入28例患者,经分子鉴定和组织学诊断4例,培养阳性24例。24例NTM培养均为快速生长分枝杆菌,以脓肿分枝杆菌复合体为主(75%),平均阳性培养时间为11.8 d。病灶的平均潜伏期为3周,而诊断的平均时间为9.8周。治疗通常需要长期的多种药物治疗。手术干预可缩短病程。结论:美容相关皮肤NTM感染常被忽视,难以诊断,导致治疗延误。我们的目的是提高临床医生对NTM感染的认识,以促进早期发现和及时治疗。在没有药敏结果的情况下,可以考虑克拉霉素和莫西沙星的经验性治疗,但应根据药敏试验结果仔细指导治疗决策。手术干预可能是有益的,当对克拉霉素耐药时,替加环素是一种可行的选择。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Infection and Drug Resistance
Infection and Drug Resistance Medicine-Pharmacology (medical)
CiteScore
5.60
自引率
7.70%
发文量
826
审稿时长
16 weeks
期刊介绍: About Journal Editors Peer Reviewers Articles Article Publishing Charges Aims and Scope Call For Papers ISSN: 1178-6973 Editor-in-Chief: Professor Suresh Antony An international, peer-reviewed, open access journal that focuses on the optimal treatment of infection (bacterial, fungal and viral) and the development and institution of preventative strategies to minimize the development and spread of resistance.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信